Supernus Pharmaceuticals | Eiendeler

Created with Highcharts 10.1.0Chart context menu1.24B1.33B1.43B1.53B1.63B1.74B1.83B
2022Q32023Q32024Q3


Assets Endring Dato
Abbott USD 81.41B 7.06B 2024-12
ANI Pharmaceuticals USD 1.28B 3.68M 2024-12
Aurora Cannabis CAD 866.52M 57.75M 2024-12
Bristol-Myers Squibb USD 92.6B 1.07B 2024-12
Canopy Growth CAD 1.16B 68.13M 2024-12
Corcept Therapeutics USD 840.55M 56.3M 2024-12
Eisai JPY 1.43T 111.45B 2024-12
Eli Lilly USD 78.71B 3.11B 2024-12
Indivior 1.46B 71M 2024-09
Novo Nordisk 397.44B 28.06B 2024-09
Pacira USD 1.55B 31.82M 2024-12
Perrigo USD 9.65B 1.56B 2024-12
Pfizer USD 213.4B 6.08B 2024-12
Supernus Pharmaceuticals USD 1.37B 25.37M 2024-12
United Therapeutics USD 7.36B 240.9M 2024-12
Xeris Pharmaceuticals USD 323.06M 1.96M 2024-12



Supernus Pharmaceuticals Eiendeler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.